Jonathan W. Kotula

1.4k total citations · 1 hit paper
8 papers, 1.0k citations indexed

About

Jonathan W. Kotula is a scholar working on Molecular Biology, Infectious Diseases and Clinical Biochemistry. According to data from OpenAlex, Jonathan W. Kotula has authored 8 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 2 papers in Infectious Diseases and 2 papers in Clinical Biochemistry. Recurrent topics in Jonathan W. Kotula's work include Gut microbiota and health (3 papers), Bacterial Genetics and Biotechnology (2 papers) and Metabolism and Genetic Disorders (2 papers). Jonathan W. Kotula is often cited by papers focused on Gut microbiota and health (3 papers), Bacterial Genetics and Biotechnology (2 papers) and Metabolism and Genetic Disorders (2 papers). Jonathan W. Kotula collaborates with scholars based in United States. Jonathan W. Kotula's co-authors include Pamela A. Silver, S. Jordan Kerns, Jeffrey C. Way, Layla Siraj, Lev Shaket, James J. Collins, Roderick T. Bronson, Michael Baym, Tobias W. Giessen and David T. Riglar and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Nature Biotechnology.

In The Last Decade

Jonathan W. Kotula

8 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An engineered E. coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans

2019 280 citations Caroline Kurtz, Yves Millet et al. Science Translational Medicine profile →

Peers

Countries citing papers authored by Jonathan W. Kotula

Since Specialization

Citations

This map shows the geographic impact of Jonathan W. Kotula's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan W. Kotula with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan W. Kotula more than expected).

Fields of papers citing papers by Jonathan W. Kotula

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan W. Kotula. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan W. Kotula. The network helps show where Jonathan W. Kotula may publish in the future.

Co-authorship network of co-authors of Jonathan W. Kotula

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan W. Kotula. A scholar is included among the top collaborators of Jonathan W. Kotula based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan W. Kotula. Jonathan W. Kotula is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	An engineered E. coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans breakdown → 2019 ·Science Translational Medicine ·Caroline Kurtz, Yves Millet, Marja Puurunen, Mylène Perreault, Mark R. Charbonneau, Vincent M. Isabella, Jonathan W. Kotula, (unknown), Yossi Dagon, William S. Denney, David A. Wagner, Kip A. West, (unknown), Aoife M. Brennan, Paul Miller	280
2	Repeated Measures of Blood and Breath Ammonia in Response to Control, Moderate and High Protein Dose in Healthy Men 2018 ·Scientific Reports ·Lisa A. Spacek, (unknown), Saurabh Saha, Jonathan W. Kotula, (unknown), (unknown), Terence H. Risby, Steven F. Solga	21
3	Engineered bacteria can function in the mammalian gut long-term as live diagnostics of inflammation 2017 ·Nature Biotechnology ·David T. Riglar, Tobias W. Giessen, Michael Baym, S. Jordan Kerns, Matthew J. Niederhuber, Roderick T. Bronson, Jonathan W. Kotula, Georg K. Gerber, Jeffrey C. Way, Pamela A. Silver	275
4	Translational Development of Microbiome‐Based Therapeutics: Kinetics of E. coli Nissle and Engineered Strains in Humans and Nonhuman Primates 2017 ·Clinical and Translational Science ·Caroline Kurtz, William S. Denney, Larry Blankstein, (unknown), (unknown), Jonathan W. Kotula, Saurabh Saha, Paul Miller, Aoife M. Brennan	29
5	A distributed cell division counter reveals growth dynamics in the gut microbiota 2015 ·Nature Communications ·Cameron Myhrvold, Jonathan W. Kotula, Wade M. Hicks, Nicholas Conway, Pamela A. Silver	38
6	Targeted Disruption of β-Arrestin 2-Mediated Signaling Pathways by Aptamer Chimeras Leads to Inhibition of Leukemic Cell Growth 2014 ·PLoS ONE ·Jonathan W. Kotula, Jin‐Peng Sun, Margie Li, (unknown), Mark Fereshteh, (unknown), Bruce A. Sullenger, Jeffrey J. Kovacs	42
7	Programmable bacteria detect and record an environmental signal in the mammalian gut 2014 ·Proceedings of the National Academy of Sciences ·Jonathan W. Kotula, S. Jordan Kerns, Lev Shaket, Layla Siraj, James J. Collins, Jeffrey C. Way, Pamela A. Silver	253
8	Aptamer-Mediated Delivery of Splice-Switching Oligonucleotides to the Nuclei of Cancer Cells 2012 ·Nucleic Acid Therapeutics ·Jonathan W. Kotula, (unknown), Xin Ming, Osamu Nakagawa, Rudolph L. Juliano, Bruce A. Sullenger	97

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact